Report cover image

Metabolomics Market: Global Market Size, Forecast, Insights, and Competitive Landscape

Publisher Prodture
Published Oct 18, 2024
Length 133 Pages
SKU # PROD19315096

Description

Metabolomics Market: Global Market Size, Forecast, Insights, and Competitive Landscape


The global metabolomics market is expected to grow at a CAGR of around 12.3% during 2025-2034. This report on global metabolomics market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global metabolomics market by segmenting the market based on product, indication, application, and region. Also, detailed profiles of companies operating in the metabolomics market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

· Growing Geriatric Population
· Rising Adoption Rate of Metabolomics as a Research and Development Tool

Market Challenges

· High Cost of Metabolomic Instruments

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Product

· Metabolomics Instruments
· Metabolomics Bioinformatics Tools and Services

Market by Indication

· Cancer
· Cardiovascular Disorders
· Neurological Disorders
· Inborn Errors of Metabolism
· Others

Market by Application

· Biomarker and Drug Discovery
· Toxicology
· Nutrigenomics
· Personalized Medicine
· Others

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

Table of Contents

133 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Metabolomics Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Metabolomics Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
5. Global Metabolomics Market by Product
5.1. Introduction
5.2. Metabolomics Instruments
5.3. Metabolomics Bioinformatics Tools and Services
6. Global Metabolomics Market by Indication
6.1. Introduction
6.2. Cancer
6.3. Cardiovascular Disorders
6.4. Neurological Disorders
6.5. Inborn Errors of Metabolism
6.6. Others
7. Global Metabolomics Market by Application
7.1. Introduction
7.2. Biomarker and Drug Discovery
7.3. Toxicology
7.4. Nutrigenomics
7.5. Personalized Medicine
7.6. Others
8. Global Metabolomics Market by Region
8.1. Introduction
8.2. Europe
8.2.1.Germany
8.2.2.United Kingdom
8.2.3.France
8.2.4.Italy
8.2.5.Spain
8.2.6.Russia
8.2.7.Netherlands
8.2.8.Rest of the Europe
8.3. North America
8.3.1.United States
8.3.2.Canada
8.4. Asia Pacific
8.4.1.China
8.4.2.Japan
8.4.3.India
8.4.4.South Korea
8.4.5.Australia
8.4.6.Indonesia
8.4.7.Rest of the Asia Pacific
8.5. Latin America
8.5.1.Mexico
8.5.2.Brazil
8.5.3.Argentina
8.5.4.Rest of Latin America
8.6. Middle East & Africa
8.6.1.Saudi Arabia
8.6.2.Turkey
8.6.3.Iran
8.6.4.United Arab Emirates
8.6.5.Rest of Middle East & Africa
9. SWOT Analysis
10. Porter’s Five Forces
11. Market Value Chain Analysis
12. Competitive Landscape
12.1. Competitive Scenario
12.2. Company Profiles
12.2.1. Agilent Technologies Inc.
12.2.2. Biocrates Life Sciences AG
12.2.3. Bio-Rad Laboratories Inc.
12.2.4. Bruker Corporation
12.2.5. Danaher Corporation
12.2.6. Human Metabolome Technologies Inc.
12.2.7. Metabolon Inc.
12.2.8. Shimadzu Corporation
12.2.9. Thermo Fisher Scientific Inc.
12.2.10. Waters Corporation Ltd.
List of Figures
Figure 1: Global Metabolomics Market (in US$ Million), 2020-2024
Figure 2: Global Metabolomics Market by Product, 2024
Figure 3: Global Metabolomics Market by Indication, 2024
Figure 4: Global Metabolomics Market by Application, 2024
Figure 5: Global Metabolomics Market by Region, 2024
Figure 6: Global Metabolomics Market (in US$ Million), 2025-2034
Figure 7: Global Metabolomics Market by Product (in %), 2024 & 2034
Figure 8: Global Metabolomics Instruments Market (in US$ Million), 2020-2024
Figure 9: Global Metabolomics Instruments Market (in US$ Million), 2025-2034
Figure 10: Global Metabolomics Bioinformatics Tools and Services Market (in US$ Million), 2020-2024
Figure 11: Global Metabolomics Bioinformatics Tools and Services Market (in US$ Million), 2025-2034
Figure 12: Global Metabolomics Market by Indication (in %), 2024 & 2034
Figure 13: Global Cancer Metabolomics Market (in US$ Million), 2020-2024
Figure 14: Global Cancer Metabolomics Market (in US$ Million), 2025-2034
Figure 15: Global Cardiovascular Disorders Metabolomics Market (in US$ Million), 2020-2024
Figure 16: Global Cardiovascular Disorders Metabolomics Market (in US$ Million), 2025-2034
Figure 17: Global Neurological Disorders Metabolomics Market (in US$ Million), 2020-2024
Figure 18: Global Neurological Disorders Metabolomics Market (in US$ Million), 2025-2034
Figure 19: Global Inborn Errors of Metabolism Metabolomics Market (in US$ Million), 2020-2024
Figure 20: Global Inborn Errors of Metabolism Metabolomics Market (in US$ Million), 2025-2034
Figure 21: Global Other Products Metabolomics Market (in US$ Million), 2020-2024
Figure 22: Global Other Products Metabolomics Market (in US$ Million), 2025-2034
Figure 23: Global Metabolomics Market by Application (in %), 2024 & 2034
Figure 24: Global Biomarker and Drug Discovery Metabolomics Market (in US$ Million), 2020-2024
Figure 25: Global Biomarker and Drug Discovery Metabolomics Market (in US$ Million), 2025-2034
Figure 26: Global Toxicology Metabolomics Market (in US$ Million), 2020-2024
Figure 27: Global Toxicology Metabolomics Market (in US$ Million), 2025-2034
Figure 28: Global Nutrigenomics Metabolomics Market (in US$ Million), 2020-2024
Figure 29: Global Nutrigenomics Metabolomics Market (in US$ Million), 2025-2034
Figure 30: Global Personalized Medicine Metabolomics Market (in US$ Million), 2020-2024
Figure 31: Global Personalized Medicine Metabolomics Market (in US$ Million), 2025-2034
Figure 32: Global Other Applications Metabolomics Market (in US$ Million), 2020-2024
Figure 33: Global Other Applications Metabolomics Market (in US$ Million), 2025-2034
Figure 34: Global Metabolomics Market by Region (in %), 2024 & 2034
Figure 35: Europe Metabolomics Market (in US$ Million), 2020-2024
Figure 36: Europe Metabolomics Market (in US$ Million), 2025-2034
Figure 37: Europe Metabolomics Market by Country (in %), 2024 & 2034
Figure 38: Germany Metabolomics Market (in US$ Million), 2020-2034
Figure 39: United Kingdom Metabolomics Market (in US$ Million), 2020-2034
Figure 40: France Metabolomics Market (in US$ Million), 2020-2034
Figure 41: Italy Metabolomics Market (in US$ Million), 2020-2034
Figure 42: Spain Metabolomics Market (in US$ Million), 2020-2034
Figure 43: Russia Metabolomics Market (in US$ Million), 2020-2034
Figure 44: Netherlands Metabolomics Market (in US$ Million), 2020-2034
Figure 45: North America Metabolomics Market (in US$ Million), 2020-2024
Figure 46: North America Metabolomics Market (in US$ Million), 2025-2034
Figure 47: North America Metabolomics Market by Country (in %), 2024 & 2034
Figure 48: United States Metabolomics Market (in US$ Million), 2020-2034
Figure 49: Canada Metabolomics Market (in US$ Million), 2020-2034
Figure 50: Asia Pacific Metabolomics Market (in US$ Million), 2020-2024
Figure 51: Asia Pacific Metabolomics Market (in US$ Million), 2025-2034
Figure 52: Asia Pacific Metabolomics Market by Country (in %), 2024 & 2034
Figure 53: China Metabolomics Market (in US$ Million), 2020-2034
Figure 54: Japan Metabolomics Market (in US$ Million), 2020-2034
Figure 55: India Metabolomics Market (in US$ Million), 2020-2034
Figure 56: South Korea Metabolomics Market (in US$ Million), 2020-2034
Figure 57: Australia Metabolomics Market (in US$ Million), 2020-2034
Figure 58: Indonesia Metabolomics Market (in US$ Million), 2020-2034
Figure 59: Latin America Metabolomics Market (in US$ Million), 2020-2024
Figure 60: Latin America Metabolomics Market (in US$ Million), 2025-2034
Figure 61: Latin America Metabolomics Market by Country (in %), 2024 & 2034
Figure 62: Mexico Metabolomics Market (in US$ Million), 2020-2034
Figure 63: Brazil Metabolomics Market (in US$ Million), 2020-2034
Figure 64: Argentina Metabolomics Market (in US$ Million), 2020-2034
Figure 65: Middle East & Africa Metabolomics Market (in US$ Million), 2020-2024
Figure 66: Middle East & Africa Metabolomics Market (in US$ Million), 2025-2034
Figure 67: Middle East & Africa Metabolomics Market by Country (in %), 2024 & 2034
Figure 68: Saudi Arabia Metabolomics Market (in US$ Million), 2020-2034
Figure 69: Turkey Metabolomics Market (in US$ Million), 2020-2034
Figure 70: Iran Metabolomics Market (in US$ Million), 2020-2034
Figure 71: UAE Metabolomics Market (in US$ Million), 2020-2034
Figure 72: Market Value Chain
List of Tables
Table 1: Global Metabolomics Market Portraiture
Table 2: Global Metabolomics Market by Product (in US$ Million), 2024 & 2034
Table 3: Global Metabolomics Market by Indication (in US$ Million), 2024 & 2034
Table 4: Global Metabolomics Market by Application (in US$ Million), 2024 & 2034
Table 5: Global Metabolomics Market by Region (in US$ Million), 2024 & 2034
Table 6: Europe Metabolomics Market by Country (in US$ Million), 2024 & 2034
Table 7: North America Metabolomics Market by Country (in US$ Million), 2024 & 2034
Table 8: Asia Pacific Metabolomics Market by Country (in US$ Million), 2024 & 2034
Table 9: Latin America Metabolomics Market by Country (in US$ Million), 2024 & 2034
Table 10: Middle East & Africa Metabolomics Market by Country (in US$ Million), 2024 & 2034
Table 11: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us